Letermovir is a quinazoline antiviral medication utilized for the prophylaxis of cytomegalovirus (CMV) infection in transplant recipients. This category provides an extensive range of Letermovir reference… Read more



































Letermovir is a quinazoline antiviral medication utilized for the prophylaxis of cytomegalovirus (CMV) infection in transplant recipients. This category provides an extensive range of Letermovir reference standards, including its metabolites, structural analogs, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous quality control and analytical method validation. By utilizing these characterized standards, researchers can effectively conduct impurity profiling to identify and quantify degradation products, such as oxidation byproducts and hydrolysis fragments, that may form during drug manufacturing or storage. The availability of these specialized compounds ensures that analytical procedures remain accurate, supporting the compliance and safety requirements inherent in the development and routine testing of this specific CMV DNA terminase complex inhibitor.